Published in Medical Devices and Surgical Technology Week, November 27th, 2005
"Ramp and burst pacing as treatment" for AT, a "known trigger mechanism of atrial fibrillation (AF), are available in permanent pacemakers to reduce the burden of AF," according to cardiologists in Norway, who performed an "analysis of the success rate of three consecutive antitachycardia pacing sequences."
"The AT 500 (Medtronic) pacemaker was implanted in 36 patients (18 female, mean age 77±11 years) with pacemaker indication due to tachybrady arrhythmias (n=34) and other indications (n=2)," explained P. Schuster and coauthors at the University of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.